Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03399266
Other study ID # SOR-0019-17-CTIL
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 1, 2018
Est. completion date March 2021

Study information

Verified date November 2018
Source Soroka University Medical Center
Contact Gil Gutvirtz, MD
Phone 972509630022
Email Giltzik@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A prospective randomized controlled trial to evaluate the safety and efficacy of labor induction with a double balloon catheter (Atad Ripener Device) in women desiring TOLAC (trial of labor after cesarean) with PROM (pre labor rupture of membranes).


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date March 2021
Est. primary completion date March 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria:

Only patients who meet the following criteria will be approached.

1. Singleton Pregnancy

2. Previous single cesarean section

3. At least 12 months have elapsed since the previous caesarean delivery

4. Diagnosed with confirmed PROM at = 34 weeks' gestation.

5. Ruptured membranes have occurred =24 hours prior to inclusion in the study.

6. Vertex presentation well applied to the cervix

7. Found to have an unripe cervix in a speculum examination (Bishop score =6).

8. Absence of significant and regular uterine contraction (<3/10Min).

9. Willingness to comply with the protocol for the duration of the study.

10. Have signed an informed consent (including a TOLAC consent form).

Exclusion Criteria:

Patients having any of the following conditions will be excluded from the study:

1. Any contraindication for a vaginal delivery (i.e. placenta previa, non-vertex presentation, previous cesarean delivery < 12 months).

2. Regular uterine contractions (>3/10Min).

3. Diagnosis of ruptured membranes was made over 24 hours prior to study inclusion.

4. Meconium stained amniotic fluid.

5. Evidence of chorio-amnionitis (T 37.6°C with uterine tenderness and maternal or fetal tachycardia or purulent discharge or WBC20.000)

6. Suspected placental abruption or a significant hemorrhage.

7. Non-reassuring fetal status (as determined by fetal heart rate monitoring and/or bio-physical profile) necessitating immediate intervention.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Double Balloon catheter for induction of labor
With the patient in lithotomy position or lying supine in bed, a speculum is inserted to visualise the cervix. The device is inserted into the cervix using long forceps until both balloons enter the cervical canal. Then, the uterine balloon is inflated with 20 ml of saline (by means of a 20 ml syringe). The device is then pulled out until stopped by the uterine balloon covering the internal cervical os. At this point the cervico-vaginal balloon located at the external os is inflated with 20 ml of saline and the speculum is removed. Then both balloons are additionally inflated with alternate increments of 20 ml normal saline to a total volume of 80 ml in each balloon. The device is loosely taped to the patient's inner thigh.

Locations

Country Name City State
Israel Soroka University Medical Center Be'er Sheva

Sponsors (1)

Lead Sponsor Collaborator
Soroka University Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Vaginal birth after cesarean (VBAC) rates 5 days
Secondary PROM to delivery interval (time) 5 days
Secondary intrapartum and post-partum infection rates 5 days
Secondary Cesarean section rates 5 days
See also
  Status Clinical Trial Phase
Recruiting NCT05333731 - Oxytocin Induction in Full Term Pregnant Women With Cesarean Section of Prelabor Rupture of Membranes
Recruiting NCT04558996 - Spanish Registry of Pregnant Women With COVID-19
Not yet recruiting NCT05430711 - Dinoprostone Induction vs. Expectant Management After PROM at Term Phase 4
Not yet recruiting NCT00294242 - Safety Study of Membrane Sweeping in Pregnancy Phase 3
Completed NCT05215873 - Induction of Labor in Pregnant Women With Prelabor Rupture of Membranes - Oxytocin or Misoprostol Phase 4
Recruiting NCT04143685 - Labor Induction With Misoprostol Versus Oxytocin in Women With Premature Rupture of Membranes N/A